98%
921
2 minutes
20
Background: Patients with diabetes mellitus (DM) face a significantly elevated risk of cardiovascular disease (CVD). However, existing risk stratification tools (e.g., Framingham Risk Score) perform suboptimally in diabetic populations. Traditional biomarkers (e.g., hs-CRP, NT-proBNP) and single-modality imaging parameters (e.g., coronary artery calcium score) have limitations, necessitating a multimodal approach to enhance predictive accuracy.
Objective: To develop and validate a multimodal diagnostic model integrating novel biomarkers (sST2, GDF-15) and imaging parameters (coronary artery calcium score [CACS], carotid plaque characteristics) for predicting cardiovascular complications in diabetic patients and to evaluate its clinical utility.
Methods: This single-center retrospective cohort study included 600 adults with type 2 diabetes (2015-2023) and no baseline cardiovascular disease. Laboratory biomarkers (sST2, GDF-15, HbA1c), imaging parameters (CACS, carotid plaque ulceration), and clinical variables were collected. Predictors were selected via LASSO regression, and a multimodal logistic regression model was constructed. Model performance was assessed using ROC curves (AUC), net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA).
Results: The final model incorporated sST2, GDF-15, CACS, ulcerated carotid plaques, HbA1c, and SGLT2i use. In the validation cohort, the multimodal model achieved an AUC of 0.811 (95% CI: 0.73-0.83), outperforming biomarker-only (AUC = 0.774) and imaging-only models (AUC = 0.735). NRI and IDI were 0.52 (p < 0.001) and 0.09 (p < 0.001), respectively. DCA demonstrated superior clinical net benefit for the combined model across threshold probabilities (10-30%), with a net benefit of 0.32 at 20% risk threshold. Sensitivity and subgroup analyses confirmed model stability.
Conclusion: The integration of biomarkers and imaging parameters significantly improves cardiovascular risk prediction in diabetic patients, offering enhanced clinical utility. Future multicenter prospective studies are strongly warranted to validate generalizability and cost-effectiveness.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12232027 | PMC |
http://dx.doi.org/10.1186/s12872-025-04916-0 | DOI Listing |
PLoS One
September 2025
Department of Radiation Oncology, Yonsei Cancer Center, Heavy Ion Therapy Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Volumetric modulated arc therapy (VMAT) for lung cancer involves complex multileaf collimator (MLC) motion, which increases sensitivity to interplay effects with tumour motion. Current dynamic conformal arc methods address this issue but may limit the achievable dose distribution optimisation compared with standard VMAT. This study examined the clinical utility of a VMAT technique with monitor unit limits (VMATliMU) to mimic conformal arc delivery and reduce interplay effects while maintaining plan quality.
View Article and Find Full Text PDFIEEE Trans Biomed Eng
September 2025
Objective: Diffusion magnetic resonance imaging (dMRI) often suffers from low spatial and angular resolution due to inherent limitations in imaging hardware and system noise, adversely affecting the accurate estimation of microstructural parameters with fine anatomical details. Deep learning-based super-resolution techniques have shown promise in enhancing dMRI resolution without increasing acquisition time. However, most existing methods are confined to either spatial or angular super-resolution, disrupting the information exchange between the two domains and limiting their effectiveness in capturing detailed microstructural features.
View Article and Find Full Text PDFIEEE Trans Neural Netw Learn Syst
September 2025
Temporal modeling plays an important role in the effective adaption of the powerful pretrained text-image foundation model into text-video retrieval. However, existing methods often rely on additional heavy trainable modules, such as transformer or BiLSTM, which are inefficient. In contrast, we avoid introducing such heavy components by leveraging frozen foundation models.
View Article and Find Full Text PDFJ Thromb Thrombolysis
September 2025
Central Laboratory of Yongchuan Hospital, Chongqing Medical University, No. 439, Xuanhua Road, Yongchuan District, Chongqing, 402160, China.
In vitro assessment of the inhibitory effect of antiplatelet drugs on platelet aggregation is frequently employed to guide personalized antiplatelet therapy in clinical practice. However, existing methods for detecting platelet aggregation rely heavily on high concentrations of exogenous agonists, which may obscure part of the inhibitory effect of antiplatelet drugs and lead to an underestimation of their effects. This study validates a novel analytical strategy for evaluating the effects of antiplatelet drugs by quantifying the microscopic three-dimensional morphological parameters of platelet aggregates formed through spontaneous aggregation on a glass surface.
View Article and Find Full Text PDFEgypt Heart J
September 2025
Department of Cardiology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Background: Long-term outcomes of transcatheter mitral valve edge-to-edge repair (TEER) are compared with medical therapy remain under investigation. This study evaluated the 3-year effects of MitraClip on mitral regurgitation (MR) severity, ventricular remodeling, and clinical outcomes in high surgical-risk patients.
Methods: A single-center retrospective cohort included 31 MitraClip patients (2016-2023) and 30 contemporaneous controls on maximally tolerated guideline-directed medical therapy.